CADL - Candel Therapeutics receives FDA orphan drug designation for its pancreatic cancer treatment
2024-04-11 09:18:43 ET
More on Candel Therapeutics
- Candel stock soars on positive data from mid-stage pancreatic cancer drug trial
- Krystal Biotech, Candel, Edgewise gain after FDA fast track tags
- Seeking Alpha’s Quant Rating on Candel Therapeutics
- Historical earnings data for Candel Therapeutics
- Financial information for Candel Therapeutics